AU1578395A - Use of insulin sensitisers for treating renal diseases - Google Patents

Use of insulin sensitisers for treating renal diseases

Info

Publication number
AU1578395A
AU1578395A AU15783/95A AU1578395A AU1578395A AU 1578395 A AU1578395 A AU 1578395A AU 15783/95 A AU15783/95 A AU 15783/95A AU 1578395 A AU1578395 A AU 1578395A AU 1578395 A AU1578395 A AU 1578395A
Authority
AU
Australia
Prior art keywords
renal diseases
treating renal
insulin sensitisers
sensitisers
insulin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU15783/95A
Other versions
AU700826B2 (en
Inventor
Robin Edwin Buckingham
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9402624A external-priority patent/GB9402624D0/en
Priority claimed from GB9410214A external-priority patent/GB9410214D0/en
Priority claimed from GBGB9426019.7A external-priority patent/GB9426019D0/en
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of AU1578395A publication Critical patent/AU1578395A/en
Application granted granted Critical
Publication of AU700826B2 publication Critical patent/AU700826B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU15783/95A 1994-02-10 1995-02-07 Use of insulin sensitisers for treating renal diseases Ceased AU700826B2 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GB9402624A GB9402624D0 (en) 1994-02-10 1994-02-10 Novel method
GB9402624 1994-02-10
GB9410214A GB9410214D0 (en) 1994-05-21 1994-05-21 Novel method
GB9410214 1994-05-21
GB9426019 1994-12-22
GBGB9426019.7A GB9426019D0 (en) 1994-12-22 1994-12-22 Novel method
PCT/EP1995/000441 WO1995021608A1 (en) 1994-02-10 1995-02-07 Use of insulin sensitisers for treating renal diseases

Publications (2)

Publication Number Publication Date
AU1578395A true AU1578395A (en) 1995-08-29
AU700826B2 AU700826B2 (en) 1999-01-14

Family

ID=27267046

Family Applications (1)

Application Number Title Priority Date Filing Date
AU15783/95A Ceased AU700826B2 (en) 1994-02-10 1995-02-07 Use of insulin sensitisers for treating renal diseases

Country Status (11)

Country Link
EP (1) EP0777469A1 (en)
JP (1) JPH09512249A (en)
CN (2) CN1083715C (en)
AP (1) AP553A (en)
AU (1) AU700826B2 (en)
CA (1) CA2182986A1 (en)
IL (1) IL112590A (en)
MX (1) MX9603338A (en)
SG (1) SG47100A1 (en)
TW (1) TW475896B (en)
WO (1) WO1995021608A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA973850B (en) * 1996-05-06 1997-12-02 Reddy Research Foundation Novel antidiabetic compounds having hypolipidaemic, anti-hypertensive properties, process for their preparation and pharmaceutical compositions containing them.
ZA973848B (en) * 1996-05-06 1997-12-02 Reddy Research Foundation Novel heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them.
US5919782A (en) * 1996-05-06 1999-07-06 Dr. Reddy's Research Foundation Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
US5885997A (en) * 1996-07-01 1999-03-23 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
US6114526A (en) * 1996-07-01 2000-09-05 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
US6372750B2 (en) 1996-07-01 2002-04-16 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compounds containing them and their use in the treatment of diabetes and related diseases
USRE39266E1 (en) * 1996-07-01 2006-09-05 Dr. Reddy's Laboratories, Limited Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
US5985884A (en) * 1996-07-01 1999-11-16 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
US6313113B1 (en) 1997-04-15 2001-11-06 Reddy-Cheminor, Inc. Heterocyclic compounds having antidiabetic, hypolipidemic and antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
US6011031A (en) * 1997-05-30 2000-01-04 Dr. Reddy's Research Foundation Azolidinediones useful for the treatment of diabetes, dyslipidemia and hypertension: process for their preparation and pharmaceutical compositions containing them
GB9711683D0 (en) * 1997-06-05 1997-08-06 Smithkline Beecham Plc Composition
US20020137940A1 (en) 1997-12-16 2002-09-26 Smithkline Beecham P.L.C. 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical
GB9726563D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726566D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
OA11871A (en) 1999-04-23 2006-03-27 Smithkline Beecham Plc Novel pharmaceutical.
BR0013375A (en) * 1999-08-17 2002-07-23 Smithkline Beecham Plc Pharmaceutical compositions containing thiazolidinedione derivatives and process for their preparation
EP1284291A4 (en) * 2000-05-25 2005-06-08 Yamanouchi Pharma Co Ltd Human pgc-1 promoter
GB0019223D0 (en) * 2000-08-04 2000-09-27 Smithkline Beecham Plc Novel pharmaceutical
JP2008531707A (en) 2005-03-03 2008-08-14 スミスクライン ビーチャム コーポレーション Medicine
EP2155769B1 (en) 2007-05-04 2012-06-27 Katholieke Universiteit Leuven KU Leuven Research & Development Tissue degeneration protection

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0842925A1 (en) * 1987-09-04 1998-05-20 Beecham Group Plc Substituted thiazolidinedione derivatives
GB9023584D0 (en) * 1990-10-30 1990-12-12 Beecham Group Plc Novel compounds
FR2680512B1 (en) * 1991-08-20 1995-01-20 Adir NOVEL 2,4-THIAZOLIDINEDIONE DERIVATIVES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
JPH05310719A (en) * 1992-04-28 1993-11-22 Terumo Corp Thiazolidine-2,4-dione derivative

Also Published As

Publication number Publication date
CN1083715C (en) 2002-05-01
EP0777469A1 (en) 1997-06-11
CN1318372A (en) 2001-10-24
IL112590A (en) 2002-08-14
WO1995021608A1 (en) 1995-08-17
AP553A (en) 1996-11-06
AP9500717A0 (en) 1995-04-30
SG47100A1 (en) 1998-03-20
JPH09512249A (en) 1997-12-09
IL112590A0 (en) 1995-06-29
CA2182986A1 (en) 1995-08-17
MX9603338A (en) 1997-03-29
TW475896B (en) 2002-02-11
CN1145027A (en) 1997-03-12
AU700826B2 (en) 1999-01-14

Similar Documents

Publication Publication Date Title
AU1578395A (en) Use of insulin sensitisers for treating renal diseases
AU7867994A (en) Hemofiltration of mediator-related diseases
AU640772B2 (en) Catheter for extracorporeal treatment
AU1645595A (en) Disposable diaper
AU7194596A (en) Disposable diaper
AU6313794A (en) Method for making disposable diapers
AU6810496A (en) Disposable diaper
HK1009939A1 (en) Medicament for treating cardiac inflammatory diseases
AU1489195A (en) Disposable diaper
AU2805195A (en) Therapeutic compounds
AU5268696A (en) Novel compounds and methods for therapy
AU3201095A (en) Substituted thiazoles for the treatment of inflammation
AU7905894A (en) Treatment of poultry
AU2388895A (en) Substituted cyclopentadienyl compounds for the treatment of inflammation
AU6810396A (en) Disposable diaper
AU8800598A (en) B7-binding molecules for treating immune diseases
AU3172395A (en) Pants type disposable diaper
AU2027495A (en) Pharmaceutical composition for treating hemorrhoidal diseases
AU3187595A (en) Compounds for the treatment of restenosis
AU7310896A (en) Use of nitroflavonoids for the treatment of anxiety
AU5357696A (en) Disposable diaper
AU1645495A (en) Disposable diapers
AU2705195A (en) Incontinence treatment
AU697136B2 (en) Agents for treating metabolic bone diseases
HU9602207D0 (en) Use of insulin sensitisers for treating renal diseases